GTBP vs WAB · $17.4M cap vs P/E 38, rev $3.18B
GT Biopharma Inc (GTBP) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
GTBP does not have a complete income-statement cache yet.
Latest reported WAB revenue for 2026-06-30 was $3.18B. Net income was $395.0M. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
GTBP currently screens at market cap $17.4M. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the GTBP and WAB stock pages for the full models.
Not investment advice.